Andrew J. Westwood, MD

Academic Appointments

  • Assistant Professor of Neurology at CUMC

Dr. Westwood completed his neuroscience and medical training at Cambridge University in the United Kingdom. He was a resident in Neurology at Boston University Medical Center, where he also completed an accredited fellowship in Sleep Medicine. He has joined the Division of Epilepsy and the Sleep Disorders Center in the Department of Neurology as the first full-time sleep specialist. Apart from his interest in the care of patients with sleep disorders, Dr. Westwood has a particular interest in behavioral neurology and neurodegenerative diseases. In addition to being a Diplomate of the Royal College of Physicians in the UK, with a special certification in Neurology, Dr. Westwood is a member of the American Academy of Neurology and American Academy of Sleep Medicine. Diagnostics include polysomnography (in-lab and ambulatory with/without extended EEG montage), actigraphy, multiple sleep latency testing, and maintenance of wakefulness testing.

Departmental Appointments

  • Department of Neurology
    Division of Epilepsy and Sleep

Board Certifications

  • Sleep Medicine
  • Neurology

Areas of Expertise

  • Sleep Disorder
  • Multiple Sleep Latency Test/MSLT
  • Sleep Medicine
  • Sleep Walking

Education and Training

  • 2006 Cambridge University
  • MD, Cambridge University Medical School (United Kingdom)
  • Internship: Hospital of St Raphael
  • Residency: Boston University Medical Center
  • Fellowship: Boston University Medical Center

Locations

  • Neurological Institute of New York

    710 West 168th Street
    Floor: 7
    New York, NY 10032
    For new and current patient appointments, call:
    (646) 426-3876
  • ColumbiaDoctors Midtown

    51 West 51st Street
    New York, NY 10019
    For new and current patient appointments, call:
    (646) 426-3876

Centers / Institutes / Programs

  • Sleep Disorders Center

Practices and Centers

  • ColumbiaDoctors Midtown

Provider Affiliations

  • NewYork-Presbyterian/Columbia

Insurance Programs

Please contact the provider's office directly to verify that your particular insurance is accepted.

  • Aetna [EPO, HMO, Medicare Managed Care, NY Signature, NYP Employee Plan, POS, PPO, Signature Administrators, Student Health]
  • Affinity [Essential Plan, Medicaid Managed Care]
  • AgeWell [Medicare Managed Care, Special Needs Plan]
  • Amida Care [Special Needs Plan]
  • Capital District Physician Health Plan [Capital District Physician Health Plan]
  • Cigna [EPO, Great West, HMO, POS, PPO]
  • Emblem/GHI [Medicare Managed Care, PPO]
  • Emblem/HIP [ConnectiCare, EPO, Essential Plan, HMO, Medicaid Managed Care, Medicare Managed Care, POS, PPO, Select Care (Exchange), Vytra]
  • Empire Blue Cross Blue Shield [EPO, Medicare Managed Care, PPO]
  • Empire Blue Cross Blue Shield HealthPlus [Child/Family Health Plus, Essential Plan, Medicaid Managed Care]
  • Fidelis Care [Child/Family Health Plus, Medicaid Managed Care, Medicare Managed Care]
  • Healthfirst [Child/Family Health Plus, Leaf (Exchange), Medicaid Managed Care, Medicare Managed Care]
  • Local 1199 [Local 1199]
  • MagnaCare [MagnaCare]
  • Multiplan [Multiplan]
  • MVP Health Care [Child/Family Health Plus, Essential Plan, HMO, Medicaid Managed Care]
  • Oxford Health Plans [Freedom, Liberty]
  • UnitedHealthcare [Columbia University Employee Plan, HMO, Medicaid (Community Plan), Medicare Managed Care, POS, PPO]
  • VNSNY CHOICE [Medicare Managed Care, SelectHealth, Special Needs Plan]
  • WellCare [Medicaid Managed Care, Medicare Managed Care]

This provider accepts new patients

Appointment Phone Number: (646) 426-3876

NIH Grants

  • A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, CROSSOVER STUDY TO EVALUATE THE EFFICACY OF BTD-001 IN SUBJECTS WITH IDIOPATHIC HYPERSOMNIA (IH) (P&S Industry Clinical Trial)

    Oct 3 2018 - Oct 3 2023

    AN OPEN LABEL EXPANDED ACCESS PROGRAM INTENDED TO PROVIDE TREATMENT WITH HBS-101 (PITOLISANT) TO ADULT PATIENTS IN THE U.S. WITH EXCESSIVE DAYTIME SLEEPINESS ASSOCIATED WITH NARCOLEPSY WITH OR WITHOUT CATAPLEXY (P&S Industry Clinical Trial)

    Jul 13 2018 - Jul 13 2023

    A RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, FIXED-DOSE, MULTIPLE COHORT, MULTIPLE CROSSOVER, DOSE-FINDING STUDY OF ORAL BTD-001 IN ADULTS WITH IDIOPATHIC HYPERSOMNIA OR NARCOLEPSY TYPE 2 (P&S Industry Clinical Trial)

    Feb 9 2017 - Feb 9 2022